PFIZER MISSED DEADLINE TO TURN IN MYOCARDITIS DATA

Comments

Comments

Leave a Reply

Leave a Reply

Pfizer missed a deadline to turn over internal studies on myocarditis, per an FDA order. The deadline came and went. Now, they quietly have a new date in June. Why the delay on such important data? And, why does the FDA set arbitrary deadlines which aren’t enforced?

#VRBPAC #Myocarditis #Deadline #FDA #Pfizer